Financial News

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by Nyxoah

< Previous 1 2 Next >
Publication relating to transparency notifications
From Nyxoah
Via GlobeNewswire
Tickers NYXH
Nyxoah Announces Commercial Launch of Genio® Innovative Therapy in England
From Nyxoah
Via GlobeNewswire
Tickers NYXH
Information on the total number of voting rights and shares
From Nyxoah
Via GlobeNewswire
Tickers NYXH
Nyxoah to Participate in the Piper Sandler 36th Annual Healthcare Conference
From Nyxoah
Via GlobeNewswire
Tickers NYXH
Invitation to attend the special shareholders’ meeting of the Company to be held on December 19, 2024
From Nyxoah
Via GlobeNewswire
Tickers NYXH
Publication relating to transparency notifications
From Nyxoah
Via GlobeNewswire
Tickers NYXH
Nyxoah Reports Third Quarter Financial and Operating Results
From Nyxoah
Via GlobeNewswire
Tickers NYXH
Nyxoah Appoints John Landry as Chief Financial Officer
From Nyxoah
Via GlobeNewswire
Tickers NYXH
Publication relating to transparency notifications
From Nyxoah
Via GlobeNewswire
Tickers NYXH
Nyxoah to Release Third Quarter 2024 Financial Results on November 6, 2024
From Nyxoah
Via GlobeNewswire
Tickers NYXH
Publication relating to transparency notifications
From Nyxoah
Via GlobeNewswire
Tickers NYXH
Information on the total number of voting rights and shares
From Nyxoah
Via GlobeNewswire
Tickers NYXH
Publication relating to transparency notifications
From Nyxoah
Via GlobeNewswire
Tickers NYXH
Nyxoah Raises $27 Million through its At-the-Market Offering
From Nyxoah
Via GlobeNewswire
Tickers NYXH
DREAM Pivotal Study Data Presented at the International Surgical Sleep Society 2024 Educational Update
From Nyxoah
Via GlobeNewswire
Tickers NYXH
Information on the total number of voting rights and shares
From Nyxoah
Via GlobeNewswire
Tickers NYXH
Publication relating to transparency notifications
From Nyxoah
Via GlobeNewswire
Tickers NYXH
Nyxoah to Participate in Upcoming Investor Conferences
From Nyxoah
Via GlobeNewswire
Tickers NYXH
Nyxoah Rings the Closing Bell at Nasdaq while Preparing for U.S. Market Launch of Innovative Sleep Apnea Device
From Nyxoah
Via GlobeNewswire
Tickers NYXH
Nyxoah Reports Second Quarter and First Half 2024 Financial and Operating Results
From Nyxoah
Via GlobeNewswire
Tickers NYXH
Nyxoah to Release Second Quarter and First Half 2024 Financial Results on August 6, 2024
From Nyxoah
Via GlobeNewswire
Tickers NYXH
Nyxoah Appoints Scott Holstine as Chief Commercial Officer
From Nyxoah
Via GlobeNewswire
Tickers NYXH
Nyxoah Has Signed a €37.5 Million Loan Facility Agreement with the European Investment Bank
From Nyxoah
Via GlobeNewswire
Tickers NYXH
Nyxoah Submits Fourth and Final Module in PMA Application for Genio to the US FDA
From Nyxoah
Via GlobeNewswire
Tickers NYXH
Information on the total number of voting rights and shares
From Nyxoah
Via GlobeNewswire
Tickers NYXH
Nyxoah to Participate in the Jefferies Global Healthcare Conference
From Nyxoah
Via GlobeNewswire
Tickers NYXH
Information on the total number of voting rights and shares
From Nyxoah
Via GlobeNewswire
Tickers NYXH
Publication relating to transparency notifications
From Nyxoah
Via GlobeNewswire
Tickers NYXH
Nyxoah Announces Closing of Offering and Partial Exercise of Option to Purchase Additional Shares
From Nyxoah
Via GlobeNewswire
Tickers NYXH
Information on the Total Number of Voting Rights and Shares
From Nyxoah
Via GlobeNewswire
Tickers NYXH
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Use the myMotherLode.com Keyword Search to go straight to a specific page

Popular Pages

  • Local News
  • US News
  • Weather
  • State News
  • Events
  • Traffic
  • Sports
  • Dining Guide
  • Real Estate
  • Classifieds
  • Financial News
  • Fire Info
Terms of Service Privacy Policy
© Copyright 2000-2019 Clarke Broadcasting Corporation. All rights reserved.
Feedback